ArticlePharmaceuticals (Basel, Switzerland)2024

Mouse Type-I Interferon-Mannosylated Albumin Fusion Protein for the Treatment of Chronic Hepatitis.

Yuki Minayoshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.